Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111

1.

Development and Validation of a Combined Hypoxia and Immune Prognostic Classifier for Head and Neck Cancer.

Brooks JM, Menezes AN, Ibrahim M, Archer L, Lal N, Bagnall CJ, von Zeidler SV, Valentine HR, Spruce RJ, Batis N, Bryant JL, Hartley M, Kaul B, Ryan GB, Bao R, Khattri A, Lee SP, Ogbureke KUE, Middleton G, Tennant DA, Beggs AD, Deeks J, West CML, Cazier JB, Willcox BE, Seiwert TY, Mehanna H.

Clin Cancer Res. 2019 Sep 1;25(17):5315-5328. doi: 10.1158/1078-0432.CCR-18-3314. Epub 2019 Jun 10.

PMID:
31182433
2.

Exercise-induced myokine FNDC5/irisin functions in cardiovascular protection and intracerebral retrieval of synaptic plasticity.

Zhou X, Xu M, Bryant JL, Ma J, Xu X.

Cell Biosci. 2019 Apr 3;9:32. doi: 10.1186/s13578-019-0294-y. eCollection 2019.

3.

HIVAN associated tubular pathology with reference to ER stress, mitochondrial changes, and autophagy.

Katuri A, Bryant JL, Patel D, Patel V, Andhavarapu S, Asemu G, Davis H, Makar TK.

Exp Mol Pathol. 2019 Feb;106:139-148. doi: 10.1016/j.yexmp.2018.12.009. Epub 2018 Dec 31. Review.

PMID:
30605635
4.

Human Papillomavirus (HPV) Vaccine Effectiveness and Potential Herd Immunity for Reducing Oncogenic Oropharyngeal HPV-16 Prevalence in the United Kingdom: A Cross-sectional Study.

Mehanna H, Bryant TS, Babrah J, Louie K, Bryant JL, Spruce RJ, Batis N, Olaleye O, Jones J, Struijk L, Molijn A, Vorsters A, Rosillon D, Taylor S, D'Souza G.

Clin Infect Dis. 2019 Sep 27;69(8):1296-1302. doi: 10.1093/cid/ciy1081.

PMID:
30590469
5.

Mycoplasma promotes malignant transformation in vivo, and its DnaK, a bacterial chaperone protein, has broad oncogenic properties.

Zella D, Curreli S, Benedetti F, Krishnan S, Cocchi F, Latinovic OS, Denaro F, Romerio F, Djavani M, Charurat ME, Bryant JL, Tettelin H, Gallo RC.

Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):E12005-E12014. doi: 10.1073/pnas.1815660115. Epub 2018 Dec 3. Erratum in: Proc Natl Acad Sci U S A. 2019 Jan 7;:.

6.

Corrigendum to "AQP4 and HIVAN" Experimental and Molecular Pathology, 105(2018) 71-75.

Mubariz F, Bryant JL, Nimmagadda VKC, Ray J, Makar TK.

Exp Mol Pathol. 2018 Dec;105(3):417. doi: 10.1016/j.yexmp.2018.08.007. Epub 2018 Oct 22. No abstract available.

PMID:
30360924
7.

AQP4 and HIVAN.

Mubariz F, Bryant JL, Nimmagadda VKC, Ray J, Makar TK.

Exp Mol Pathol. 2018 Aug;105(1):71-75. doi: 10.1016/j.yexmp.2018.05.004. Epub 2018 May 18. Review. No abstract available. Erratum in: Exp Mol Pathol. 2018 Oct 22;:.

PMID:
29778884
8.

The Clinical Utility of Cell-Free DNA Measurement in Differentiated Thyroid Cancer: A Systematic Review.

Fussey JM, Bryant JL, Batis N, Spruce RJ, Hartley A, Good JS, McCabe CJ, Boelaert K, Sharma N, Mehanna H.

Front Oncol. 2018 Apr 30;8:132. doi: 10.3389/fonc.2018.00132. eCollection 2018.

9.

Glomerular mitochondrial changes in HIV associated renal injury.

Bryant JL, Guda PR, Asemu G, Subedi R, Ray S, Khalid OS, Shukla V, Patel D, Davis H, Nimmagadda VKC, Makar TK.

Exp Mol Pathol. 2018 Jun;104(3):175-189. doi: 10.1016/j.yexmp.2018.03.004. Epub 2018 Mar 31.

PMID:
29608912
10.

Renal aquaporin-4 associated pathology in TG-26 mice.

Bryant JL, Guda PR, Ray S, Asemu G, Sagi AR, Mubariz F, Arvas MI, Khalid OS, Shukla V, Nimmagadda VKC, Makar TK.

Exp Mol Pathol. 2018 Jun;104(3):239-249. doi: 10.1016/j.yexmp.2018.03.005. Epub 2018 Mar 31.

11.

Novel carbonic anhydrase IX-targeted therapy enhances the anti-tumour effects of cisplatin in small cell lung cancer.

Bryant JL, Gieling RG, Meredith SL, Allen TJ, Walker L, Telfer BA, Supuran CT, Williams KJ, White A.

Int J Cancer. 2018 Jan 1;142(1):191-201. doi: 10.1002/ijc.31042. Epub 2017 Oct 3.

12.

The refined biomimetic NeuroDigm GEL™ model of neuropathic pain in a mature rat.

Hannaman MR, Fitts DA, Doss RM, Weinstein DE, Bryant JL.

Version 2. F1000Res. 2016 Oct 13 [revised 2017 Jan 1];5:2516. doi: 10.12688/f1000research.9544.2. eCollection 2016.

13.

N-tert-Prenylation of the indole ring improves the cytotoxicity of a short antagonist G analogue against small cell lung cancer.

Offerman SC, Kadirvel M, Abusara OH, Bryant JL, Telfer BA, Brown G, Freeman S, White A, Williams KJ, Aojula HS.

Medchemcomm. 2017 Feb 17;8(3):551-558. doi: 10.1039/c6md00691d. eCollection 2017 Mar 1.

14.

Characterization of tubular liquid crystal structure in embryonic stem cell derived embryoid bodies.

Xu M, Jones OD, Wang L, Zhou X, Davis HG, Bryant JL, Ma J, Isaacs WB, Xu X.

Cell Biosci. 2017 Jan 3;7:3. doi: 10.1186/s13578-016-0130-6. eCollection 2017.

15.

Expression of HIV-1 matrix protein p17 and association with B-cell lymphoma in HIV-1 transgenic mice.

Carroll VA, Lafferty MK, Marchionni L, Bryant JL, Gallo RC, Garzino-Demo A.

Proc Natl Acad Sci U S A. 2016 Nov 15;113(46):13168-13173. Epub 2016 Oct 31.

16.

Targeting the hexosamine biosynthetic pathway and O-linked N-acetylglucosamine cycling for therapeutic and imaging capabilities in diffuse large B-cell lymphoma.

Pham LV, Bryant JL, Mendez R, Chen J, Tamayo AT, Xu-Monette ZY, Young KH, Manyam GC, Yang D, Medeiros LJ, Ford RJ.

Oncotarget. 2016 Dec 6;7(49):80599-80611. doi: 10.18632/oncotarget.12413.

17.

Irradiation Decreases the Neuroendocrine Biomarker Pro-Opiomelanocortin in Small Cell Lung Cancer Cells In Vitro and In Vivo.

Meredith SL, Bryant JL, Babur M, Riddell PW, Behrouzi R, Williams KJ, White A.

PLoS One. 2016 Feb 5;11(2):e0148404. doi: 10.1371/journal.pone.0148404. eCollection 2016.

18.

Sublethal Effects of ActiveGuard Exposure on Feeding Behavior and Fecundity of the Bed Bug (Hemiptera: Cimicidae).

Jones SC, Bryant JL, Sivakoff FS.

J Med Entomol. 2015 May;52(3):413-8. doi: 10.1093/jme/tjv008. Epub 2015 Apr 1.

PMID:
26334815
19.

Targeting hypoxia in the treatment of small cell lung cancer.

Bryant JL, Meredith SL, Williams KJ, White A.

Lung Cancer. 2014 Nov;86(2):126-32. doi: 10.1016/j.lungcan.2014.08.003. Epub 2014 Aug 27. Review.

PMID:
25201720
20.

Specific RSK kinase inhibition by dibenzyl trisulfide and implication for therapeutic treatment of cancer.

Lowe HI, Facey CO, Toyang NJ, Bryant JL.

Anticancer Res. 2014 Apr;34(4):1637-41.

PMID:
24692692
21.

Overcoming platinum resistance in preclinical models of ovarian cancer using the neddylation inhibitor MLN4924.

Jazaeri AA, Shibata E, Park J, Bryant JL, Conaway MR, Modesitt SC, Smith PG, Milhollen MA, Berger AJ, Dutta A.

Mol Cancer Ther. 2013 Oct;12(10):1958-67. doi: 10.1158/1535-7163.MCT-12-1028. Epub 2013 Aug 12.

22.

Neuroendocrine and epithelial phenotypes in small-cell lung cancer: implications for metastasis and survival in patients.

Stovold R, Meredith SL, Bryant JL, Babur M, Williams KJ, Dean EJ, Dive C, Blackhall FH, White A.

Br J Cancer. 2013 Apr 30;108(8):1704-11. doi: 10.1038/bjc.2013.112. Epub 2013 Mar 21.

23.

Behavioral Responses of the Bed Bug to Permethrin-Impregnated ActiveGuard™ Fabric.

Jones SC, Bryant JL, Harrison SA.

Insects. 2013 Jun 7;4(2):230-40. doi: 10.3390/insects4020230.

24.
25.

Molecular imaging kits for hexosamine biosynthetic pathway in oncology.

Yang DJ, Kong FL, Oka T, Bryant JL.

Curr Med Chem. 2012;19(20):3310-4. Review.

PMID:
22664248
26.

Immune activation, viral gene product expression and neurotoxicity in the HIV-1 transgenic rat.

Royal W 3rd, Zhang L, Guo M, Jones O, Davis H, Bryant JL.

J Neuroimmunol. 2012 Jun 15;247(1-2):16-24. doi: 10.1016/j.jneuroim.2012.03.015. Epub 2012 Apr 12.

27.

Contact Toxicity and Residual Efficacy of Indoxacarb against the European Earwig (Dermaptera: Forficulidae).

Jones SC, Bryant JL.

Insects. 2012 Jun 25;3(3):593-600. doi: 10.3390/insects3030593.

28.

A microRNA gene expression signature predicts response to erlotinib in epithelial cancer cell lines and targets EMT.

Bryant JL, Britson J, Balko JM, Willian M, Timmons R, Frolov A, Black EP.

Br J Cancer. 2012 Jan 3;106(1):148-56. doi: 10.1038/bjc.2011.465. Epub 2011 Nov 1.

29.

Molecular requirements for transformation of fallopian tube epithelial cells into serous carcinoma.

Jazaeri AA, Bryant JL, Park H, Li H, Dahiya N, Stoler MH, Ferriss JS, Dutta A.

Neoplasia. 2011 Oct;13(10):899-911.

30.

The metastatic microenvironment: brain-residing melanoma metastasis and dormant micrometastasis.

Izraely S, Sagi-Assif O, Klein A, Meshel T, Tsarfaty G, Pasmanik-Chor M, Nahmias C, Couraud PO, Ateh E, Bryant JL, Hoon DS, Witz IP.

Int J Cancer. 2012 Sep 1;131(5):1071-82. doi: 10.1002/ijc.27324. Epub 2011 Dec 2.

31.

High-precision, three-dimensional tracking of mouse whisker movements with optical motion capture technology.

Roy S, Bryant JL, Cao Y, Heck DH.

Front Behav Neurosci. 2011 Jun 8;5:27. doi: 10.3389/fnbeh.2011.00027. eCollection 2011.

32.

New insights into HIV-1-primary skin disorders.

Cedeno-Laurent F, Gómez-Flores M, Mendez N, Ancer-Rodríguez J, Bryant JL, Gaspari AA, Trujillo JR.

J Int AIDS Soc. 2011 Jan 24;14:5. doi: 10.1186/1758-2652-14-5. Review.

33.

Randomized controlled trial of intramuscular droperidol versus midazolam for violence and acute behavioral disturbance: the DORM study.

Isbister GK, Calver LA, Page CB, Stokes B, Bryant JL, Downes MA.

Ann Emerg Med. 2010 Oct;56(4):392-401.e1. doi: 10.1016/j.annemergmed.2010.05.037.

PMID:
20868907
34.

Cerebellar cortical output encodes temporal aspects of rhythmic licking movements and is necessary for normal licking frequency.

Bryant JL, Boughter JD, Gong S, LeDoux MS, Heck DH.

Eur J Neurosci. 2010 Jul;32(1):41-52. doi: 10.1111/j.1460-9568.2010.07244.x. Epub 2010 Jun 28.

35.

The impact of a standardised intramuscular sedation protocol for acute behavioural disturbance in the emergency department.

Calver LA, Downes MA, Page CB, Bryant JL, Isbister GK.

BMC Emerg Med. 2010 Jun 28;10:14. doi: 10.1186/1471-227X-10-14.

36.

Evaluation of EVI1 and EVI1s (Delta324) as potential therapeutic targets in ovarian cancer.

Jazaeri AA, Ferriss JS, Bryant JL, Dalton MS, Dutta A.

Gynecol Oncol. 2010 Aug 1;118(2):189-95. doi: 10.1016/j.ygyno.2010.04.007. Epub 2010 May 11.

PMID:
20462630
37.
38.

Vitamin A deficiency and behavioral and motor deficits in the human immunodeficiency virus type 1 transgenic rat.

June HL, Tzeng Yang AR, Bryant JL, Jones O, Royal W 3rd.

J Neurovirol. 2009 Sep;15(5-6):380-9. doi: 10.3109/13550280903350200.

39.

Structured team approach to the agitated patient in the emergency department.

Downes MA, Healy P, Page CB, Bryant JL, Isbister GK.

Emerg Med Australas. 2009 Jun;21(3):196-202. doi: 10.1111/j.1742-6723.2009.01182.x.

PMID:
19527279
40.

A technique for stereotaxic recordings of neuronal activity in awake, head-restrained mice.

Bryant JL, Roy S, Heck DH.

J Neurosci Methods. 2009 Mar 30;178(1):75-9. doi: 10.1016/j.jneumeth.2008.11.014. Epub 2008 Nov 27.

41.

Rapamycin reduces CCR5 mRNA levels in macaques: potential applications in HIV-1 prevention and treatment.

Gilliam BL, Heredia A, Devico A, Le N, Bamba D, Bryant JL, Pauza CD, Redfield RR.

AIDS. 2007 Oct 1;21(15):2108-10.

PMID:
17885304
42.

Effect of Cnidoscolus aconitifolius leaf extract on the blood glucose and insulin levels of inbred type 2 diabetic mice.

Oladeinde FO, Kinyua AM, Laditan AA, Michelin R, Bryant JL, Denaro F, Makinde JM, Williams AL, Kennedy AP, Bronner Y.

Cell Mol Biol (Noisy-le-grand). 2007 May 15;53(3):34-41.

PMID:
17531147
43.

Innate-like gammadelta T cell responses to mycobacterium Bacille Calmette-Guerin using the public V gamma 2 repertoire in Macaca fascicularis.

Cairo C, Hebbeler AM, Propp N, Bryant JL, Colizzi V, Pauza CD.

Tuberculosis (Edinb). 2007 Jul;87(4):373-83. Epub 2007 Feb 9.

44.

A vitamin A deficient diet enhances proinflammatory cytokine, Mu opioid receptor, and HIV-1 expression in the HIV-1 transgenic rat.

Royal W 3rd, Wang H, Jones O, Tran H, Bryant JL.

J Neuroimmunol. 2007 Apr;185(1-2):29-36. Epub 2007 Feb 7.

45.
46.

Psychiatric hospitalization after deliberate self-poisoning.

Carter GL, Safranko I, Lewin TJ, Whyte IM, Bryant JL.

Suicide Life Threat Behav. 2006 Apr;36(2):213-22.

PMID:
16704325
47.

Characterization of an anti-lymphocyte function-associated antigen-1 antibody in a simian immunodeficiency virus-pig-tailed macaque (Macaca nemestrina) model.

Fletcher CA, Liao Z, Adams RJ, Carter DL, Jones OD, Davis HG, Bryant JL, Hildreth JE.

Comp Med. 2006 Feb;56(1):23-30.

PMID:
16521856
48.

A low-cost solution to measure mouse licking in an electrophysiological setup with a standard analog-to-digital converter.

Hayar A, Bryant JL, Boughter JD, Heck DH.

J Neurosci Methods. 2006 Jun 15;153(2):203-7. Epub 2005 Dec 20.

49.
50.

Effects of virus burden and chemokine expression on immunity to SHIV in nonhuman primates.

Waterman PM, Kitabwalla M, Hatfield GS, Evans PS, Lu Y, Tikhonov I, Bryant JL, Pauza CD.

Viral Immunol. 2004;17(4):545-57.

PMID:
15671751

Supplemental Content

Loading ...
Support Center